Limaye AR, Firpi RJ. Management of recurrent hepatitis C infection after liver transplantation [J]. Clin Liver Dis, 2011,15(4):845-858.
|
Pillai AA, Levitsky J. Overview of immunosuppression in liver transplantation [J]. World J Gastroenterol, 2009,15(34):4225-4233.
|
Henry SD, Metselaar HJ, Lonsdale RC, et al. Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha [J]. Gastroenterology, 2006,131(5):1452-1462.
|
Dreux M, Chisari FV. Impact of the autophagy machinery on hepatitis C virus infection [J]. Viruses, 2011,3(8):1342-1357.
|
Dreux M, Gastaminza P, Wieland SF, et al. The autophagy machinery is required to initiate hepatitis C virus replication [J]. Proc Natio Acad Sci U S A, 2009,106(33):14046-14051.
|
Tanida I, Fukasawa M, Ueno T, et al. Knockdown of autophagy-related gene decreases the production of infectious hepatitis C virus particles [J]. Autophagy, 2009,5(7):937-945.
|
Khakpoor A, Panyasrivanit M, Wikan N, et al. A role for autophagolysosomes in dengue virus 3 production in HepG2 cells [J].J Gen Virol, 2009,90(Pt 5):1093-1103.
|
Manzia TM, Angelico R, Ciano P, et al. Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients [J]. World J Gastroenterol, 2014,20(34):12217-12225.
|
Manrique A, Jimenez C, Ortega P, et al. Mycophenolate mofetil monotherapy in patients who underwent liver transplantation for hepatitis C cirrhosis [J]. Transplantat Proc, 2008,40(9):2962-2964.
|
Ye L, Li J, Zhang T, et al. Mycophenolate mofetil inhibits hepatitis C virus replication in human hepatic cells [J]. Virus Res, 2012,168(1-2):33-40.
|
Zekry A, Gleeson M, Guney S, et al. A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection [J]. Liver Transpl, 2004,10(1):52-57.
|
Kornberg A, Kupper B, Tannapfel A, et al. Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after liver transplantation [J]. Int Immunopharmacol, 2005,5(1):107-115.
|
Kabeya Y, Mizushima N, Ueno T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing [J]. EMBO J, 2000,19(21):5720-5728.
|
Tanida I, Ueno T, Kominami E. LC3 conjugation system in mammalian autophagy [J].Int J Biochemi Cell Biol, 2004,36(12):2503-2518.
|
Jordan TX, Randall G. Manipulation or capitulation: virus interactions with autophagy [J]. Microbes Infect, 2012,14(2):126-139.
|
McCoy F, Hurwitz J, McTavish N, et al. Obatoclax induces Atg7-dependent autophagy independent of beclin-1 and BAX/BAK [J]. Cell Death Dis, 2010,1:e108.
|
Sir D, Kuo CF, Tian Y, et al. Replication of hepatitis C virus RNA on autophagosomal membranes [J]. J Biol Chem, 2012,287(22):18036-18043.
|
Shrivastava S, Raychoudhuri A, Steele R, et al. Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes [J]. Hepatology, 2011,53(2):406-414.
|
Kaiser SE, Mao K, Taherbhoy AM, et al. Noncanonical E2 recruitment by the autophagy E1 revealed by Atg7-Atg3 and Atg7-Atg10 structures [J]. Nat Struct Mol Biol, 2012,19(12):1242-1249.
|
Wang J, Whiteman MW, Lian H, et al. A non-canonical MEK/ERK signaling pathway regulates autophagy via regulating Beclin 1 [J]. J Biol Chem, 2009,284(32):21412-21424.
|